Deslanoside

CAS No. 17598-65-1

Deslanoside( Deacetyllanatoside C | Desacetyllanatoside C )

Catalog No. M21488 CAS No. 17598-65-1

Deslanoside is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms. Deslanoside inhibits the Na-K-ATPase membrane pump resulting in an increase in intracellular sodium and calcium concentrations.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 256 In Stock
5MG 155 In Stock
10MG 246 In Stock
25MG 417 In Stock
50MG 586 In Stock
100MG 834 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Deslanoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Deslanoside is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms. Deslanoside inhibits the Na-K-ATPase membrane pump resulting in an increase in intracellular sodium and calcium concentrations.
  • Description
    Deslanoside is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms. Deslanoside inhibits the Na-K-ATPase membrane pump resulting in an increase in intracellular sodium and calcium concentrations.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Deacetyllanatoside C | Desacetyllanatoside C
  • Pathway
    Endocrinology/Hormones
  • Target
    ATPase
  • Recptor
    Na+/K+-ATPase
  • Research Area
    Cardiovascular Disease
  • Indication
    Congestive cardiac insufficiency arrhythmias and heart failure.

Chemical Information

  • CAS Number
    17598-65-1
  • Formula Weight
    943.1
  • Molecular Formula
    C47H74O19
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (106.04 mM)
  • SMILES
    C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3C[C@H]([C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)O)C)O)O[C@H]7C[C@@H]([C@@H]([C@H](O7)C)O[C@H]8C[C@@H]([C@@H]([C@H](O8)C)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O)O
  • Chemical Name
    4-((3S5R8R9S10S12R13S14S17R)-1214-dihydroxy-3-(((2R4S5S6R)-4-hydroxy-5-(((2S4S5S6R)-4-hydroxy-5-(((2S4S5S6R)-4-hydroxy-6-methyl-5-(((2S3R4S5S6R)-345-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1013-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hauptman PJ et al. Digitalis. Circulation. 1999 Mar 9;99(9):1265-70.
molnova catalog
related products
  • (S)-PF-03716556

    (S)-PF-03716556 can be used as an acid pump inhibitor for the treatment of disease conditions mediated by acid pump inhibitory activity.

  • Eniporide

    eniporide is a Na(+)/H(+) exchange inhibitor.

  • Goniothalamin

    Goniothalamin is a natural product that has been demonstrated to induce apoptosis in various cancer cell lines, can induce cytotoxicity and apoptosis on RT4 cells, induce apoptosis on HepG2 liver cancer cells via induction of caspase-3 with less sensitivity on the cell line of Chang cells.